首页> 美国卫生研究院文献>BMJ Open >Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial
【2h】

Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial

机译:胞浆内精子注射(ICSI)与常规体外受精(IVF)结合非严重男性不育症(NSMI-ICSI)的研究:一项多中心随机对照试验的方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionIntracytoplasmic sperm injection (ICSI), originally introduced as add-on to in vitro fertilisation (IVF) for couples with severe male infertility, is in current clinical practice also used in couples with mild male or even unexplained infertility. However, ICSI has involved unresolved concerns regarding the selection and damage to gametes and the health conditions of the offspring, and it is also labour intensive and therefore more expensive than conventional IVF. High-quality well-powered randomised clinical trials (RCTs) comparing ICSI and IVF are lacking.
机译:简介胞浆内精子注射(ICSI)最初是为患有严重男性不育症的夫妇提供的体外受精(IVF)附件,目前在临床实践中也用于患有轻度男性甚至无法解释的不育症的夫妇。但是,ICSI涉及配子的选择和损害以及后代的健康状况,尚未解决的担忧,而且它还需要大量劳动,因此比传统的IVF昂贵。缺乏比较ICSI和IVF的高质量,功能强大的随机临床试验(RCT)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号